Halberd Corp (HALB)

$0.00 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 128,000
Avg Vol 1,883,124
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Industry: Biotechnology
Sector: Healthcare
Phone: 814 786 8849
Address:
PO Box 25, Jackson Center, United States
Robjack
Robjack Dec. 6 at 12:04 AM
$HALB Anyone that thinks this new AI chapter is anything but pure theater… use your BRAIN. Halberd claims they “acquired” a revolutionary AI company called NeuroSense. So where was it before their PR? No founder, no engineers, no advisors, no LinkedIn, no papers, no customers, no history, no trace of existence outside of HALB-controlled material. Not one verifiable human being tied to it. And what legitimate AI startup in 2025 - supposedly sitting on groundbreaking behavioral-intelligence tech - chooses to be “acquired” by a zero cash, zero revenue, no R&D, endless dilution, and a decade of abandoned pivots? Answer: NONE You would have to be an absolute fucking moron to not see this for what it is: yet another manufactured scam narrative from HALB. WAKE UP. *And of course @donpberner1976 actively promoting the scam as usual.
0 · Reply
Robjack
Robjack Dec. 5 at 11:15 PM
$HALB Calling it theater is appropriate because it is ALL fictional. Hey @donpberner1976... Are these new 20-person trials going to be like the 100 person trial they claimed to be doing a year ago? This time it's different? Because hartman got a $20/mo Claude subscription!
0 · Reply
Matu83
Matu83 Dec. 5 at 3:33 PM
$HALB Years of those goals, they never progress, that's the problem, the stock price reflects inaction.
0 · Reply
donpberner1976
donpberner1976 Dec. 5 at 1:56 PM
$HALB coming to this theater: - start two 20-person clinical trials by ATP to test LDX and WatchDawg to treat PTSD and more - start second phase animal testing at MSU with the patent pending nasal spray to treat TBI - all planned trials use Artificial Intelligence to measure and speed up test results, using Halberd’s proprietary AI-platform called NeuroSense - Halberd submitted another new proposal to the CDMRP for government funding - private sector funding is next…… Company valuation is extremely low and does not reflect any of the next moves as mentioned above.
1 · Reply
donpberner1976
donpberner1976 Dec. 4 at 3:07 PM
$HALB $$$
0 · Reply
BigNasty23
BigNasty23 Dec. 4 at 2:47 PM
$HALB
0 · Reply
marvelous127
marvelous127 Dec. 4 at 2:35 PM
$HALB 🙂💲💲💲
0 · Reply
Matu83
Matu83 Dec. 3 at 7:41 PM
$HALB Clearly bullish, is red but it's up 〽️
0 · Reply
LVCREW
LVCREW Dec. 3 at 3:46 PM
$HALB
0 · Reply
donpberner1976
donpberner1976 Dec. 2 at 8:37 PM
$HALB $$$
0 · Reply
Latest News on HALB
No data available.
Robjack
Robjack Dec. 6 at 12:04 AM
$HALB Anyone that thinks this new AI chapter is anything but pure theater… use your BRAIN. Halberd claims they “acquired” a revolutionary AI company called NeuroSense. So where was it before their PR? No founder, no engineers, no advisors, no LinkedIn, no papers, no customers, no history, no trace of existence outside of HALB-controlled material. Not one verifiable human being tied to it. And what legitimate AI startup in 2025 - supposedly sitting on groundbreaking behavioral-intelligence tech - chooses to be “acquired” by a zero cash, zero revenue, no R&D, endless dilution, and a decade of abandoned pivots? Answer: NONE You would have to be an absolute fucking moron to not see this for what it is: yet another manufactured scam narrative from HALB. WAKE UP. *And of course @donpberner1976 actively promoting the scam as usual.
0 · Reply
Robjack
Robjack Dec. 5 at 11:15 PM
$HALB Calling it theater is appropriate because it is ALL fictional. Hey @donpberner1976... Are these new 20-person trials going to be like the 100 person trial they claimed to be doing a year ago? This time it's different? Because hartman got a $20/mo Claude subscription!
0 · Reply
Matu83
Matu83 Dec. 5 at 3:33 PM
$HALB Years of those goals, they never progress, that's the problem, the stock price reflects inaction.
0 · Reply
donpberner1976
donpberner1976 Dec. 5 at 1:56 PM
$HALB coming to this theater: - start two 20-person clinical trials by ATP to test LDX and WatchDawg to treat PTSD and more - start second phase animal testing at MSU with the patent pending nasal spray to treat TBI - all planned trials use Artificial Intelligence to measure and speed up test results, using Halberd’s proprietary AI-platform called NeuroSense - Halberd submitted another new proposal to the CDMRP for government funding - private sector funding is next…… Company valuation is extremely low and does not reflect any of the next moves as mentioned above.
1 · Reply
donpberner1976
donpberner1976 Dec. 4 at 3:07 PM
$HALB $$$
0 · Reply
BigNasty23
BigNasty23 Dec. 4 at 2:47 PM
$HALB
0 · Reply
marvelous127
marvelous127 Dec. 4 at 2:35 PM
$HALB 🙂💲💲💲
0 · Reply
Matu83
Matu83 Dec. 3 at 7:41 PM
$HALB Clearly bullish, is red but it's up 〽️
0 · Reply
LVCREW
LVCREW Dec. 3 at 3:46 PM
$HALB
0 · Reply
donpberner1976
donpberner1976 Dec. 2 at 8:37 PM
$HALB $$$
0 · Reply
aimfirefive
aimfirefive Dec. 2 at 6:47 PM
$HALB
0 · Reply
BigNasty23
BigNasty23 Dec. 1 at 10:21 PM
$HALB
0 · Reply
LVCREW
LVCREW Dec. 1 at 8:25 PM
$HALB
0 · Reply
marvelous127
marvelous127 Dec. 1 at 2:03 PM
$HALB 💲💲💲💲
0 · Reply
12Dakotadan
12Dakotadan Dec. 1 at 11:51 AM
$HALB
0 · Reply
donpberner1976
donpberner1976 Dec. 1 at 10:00 AM
$HALB NeuroSense AI: Advanced AI that reads behavior like code, turning neural signals into clinical insights. NeuroSense AI will speed up the next round of animal trials at MSU.
3 · Reply
Robjack
Robjack Nov. 30 at 11:08 PM
$HALB Don’t look now, but the float is now over 700m shares - and somehow the perma-bulls here STILL can’t connect the dots. Quietly bloat the share count to the edge of the 800m authorized limit, never mention it in a PR, but slip in “possible corporate restructuring” like nobody will notice. That’s not subtle - that’s reverse-split prep, plain and simple. They’re getting ready to zero you out again so they can dilute from scratch. And the funniest part? The same people getting financially skinned alive are the ones posting “bullish” and calling anyone who states basic math a “basher.”
0 · Reply
donpberner1976
donpberner1976 Nov. 28 at 9:53 PM
$HALB $$$
0 · Reply
BigNasty23
BigNasty23 Nov. 28 at 8:08 PM
$HALB
0 · Reply
Matu83
Matu83 Nov. 27 at 5:28 PM
$HALB Yes, in January 2026, you will say the same thing: "We hope for good omens for the end of the year."
0 · Reply
Staschu
Staschu Nov. 27 at 10:39 AM
$HALB Happy Thanksgiving everyone. Looking forward to a bang up end of the year! 🦃🦃🦃
0 · Reply
LVCREW
LVCREW Nov. 26 at 10:27 PM
$HALB I play the penny slots for the free beer. JACKPOT!! Happy Thanksgiving to all.
0 · Reply